Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Financial Position

v3.22.1
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current:    
Cash and cash equivalents $ 44,315 $ 37,226
Restricted cash 467 473
Accounts receivable, net 2,581 2,222
Prepaids, advances and other 2,760 2,668
Other receivables 2,803 2,396
Inventories, net 16,230 15,408
Total current assets 69,156 60,393
Investment – Cansativa 1,394 1,458
Property, plant and equipment, net of accumulated depreciation of $6,407 and $5,702 for March 31, 2022 and December 31, 2021, respectively 30,056 30,932
Intangible assets, net 22,926 23,117
Operating lease right-of-use assets, net 3,682 0
Other non-current assets 3 260
Total Assets 127,217 116,160
Current:    
Accounts payable 4,374 3,981
Accrued expenses and other current liabilities 3,112 2,898
Convertible note due 2024, current portion 15,170 16,559
Loans and borrowings, current portion 1,306 949
Warrant liability 1,715 2,205
Operating lease liabilities, current portion 1,552 0
Deferred revenue, current portion 265 653
Total current liabilities 27,494 27,245
Convertible note due 2024 0 1,140
Loans and borrowing 6,149 6,447
Deferred revenue 1,290 1,548
Operating lease liabilities — long-term 2,267 0
Deferred tax liabilities 6,650 6,650
Other long-term liabilities 919 360
Total Liabilities 44,769 43,390
Shareholders’ equity    
Common shares, without par value, unlimited shares authorized: 38,623,929 and 26,605,797 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 0 0
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of March 31, 2022 and December 31, 2021 0 0
Additional paid-in capital 213,328 187,510
Accumulated deficit (130,880) (114,740)
Total shareholders' equity 82,448 72,770
Total liabilities and shareholders' equity $ 127,217 $ 116,160